Shahid R. Merchant

Array ( [id] => 20425279 [patent_doc_number] => 20250387366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-12-25 [patent_title] => TOPICAL OCULAR DELIVERY OF CROMAKALIM [patent_app_type] => utility [patent_app_number] => 19/313605 [patent_app_country] => US [patent_app_date] => 2025-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40893 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19313605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20232478 [patent_doc_number] => 20250289797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-18 [patent_title] => SMALL MOLECULE INHIBITORS OF MAMMALIAN SLC6A19 FUNCTION [patent_app_type] => utility [patent_app_number] => 19/224188 [patent_app_country] => US [patent_app_date] => 2025-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54135 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19224188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20232479 [patent_doc_number] => 20250289798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-18 [patent_title] => SMALL MOLECULE INHIBITORS OF MAMMALIAN SLC6A19 FUNCTION [patent_app_type] => utility [patent_app_number] => 19/224208 [patent_app_country] => US [patent_app_date] => 2025-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53844 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19224208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20219820 [patent_doc_number] => 20250282751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-11 [patent_title] => SALT AND CRYSTAL FORM OF A FAK INHIBITOR [patent_app_type] => utility [patent_app_number] => 19/216569 [patent_app_country] => US [patent_app_date] => 2025-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5553 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19216569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20192173 [patent_doc_number] => 20250268883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-28 [patent_title] => THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING MOVEMENT DISORDERS [patent_app_type] => utility [patent_app_number] => 19/198458 [patent_app_country] => US [patent_app_date] => 2025-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 112861 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19198458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20714143 [patent_doc_number] => 12629367 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-05-19 [patent_title] => Five-membered ring-fused six-membered ring compound, preparation method therefor, and pharmaceutical composition and use thereof [patent_app_type] => utility [patent_app_number] => 19/189146 [patent_app_country] => US [patent_app_date] => 2025-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33624 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19189146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20164996 [patent_doc_number] => 20250257042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-14 [patent_title] => NOVEL DRP-1 INHIBITORS AS THERAPEUTIC AGENTS [patent_app_type] => utility [patent_app_number] => 19/175436 [patent_app_country] => US [patent_app_date] => 2025-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6277 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19175436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20335298 [patent_doc_number] => 20250339418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-11-06 [patent_title] => THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING MOVEMENT DISORDERS [patent_app_type] => utility [patent_app_number] => 19/092490 [patent_app_country] => US [patent_app_date] => 2025-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 112812 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19092490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20134866 [patent_doc_number] => 20250241910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-31 [patent_title] => COMBINATION THERAPY FOR THE TREATMENT OF PSYCHIATRIC DISORDER [patent_app_type] => utility [patent_app_number] => 19/067074 [patent_app_country] => US [patent_app_date] => 2025-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15164 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19067074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20315993 [patent_doc_number] => 12454535 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-10-28 [patent_title] => Substituted derivatives of isoindoles [patent_app_type] => utility [patent_app_number] => 19/034407 [patent_app_country] => US [patent_app_date] => 2025-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 8 [patent_no_of_words] => 8519 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19034407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20059206 [patent_doc_number] => 20250197428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-19 [patent_title] => INHIBITORS OF KIF18A AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 19/020085 [patent_app_country] => US [patent_app_date] => 2025-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36532 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19020085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20067017 [patent_doc_number] => 20250205239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-26 [patent_title] => COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING NEURODEGENERATIVE DISEASES [patent_app_type] => utility [patent_app_number] => 18/991922 [patent_app_country] => US [patent_app_date] => 2024-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1227 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18991922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19948321 [patent_doc_number] => 12319668 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-06-03 [patent_title] => Small molecule inhibitors of mammalian SLC6A19 function [patent_app_type] => utility [patent_app_number] => 18/977370 [patent_app_country] => US [patent_app_date] => 2024-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 3 [patent_no_of_words] => 55123 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18977370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20414101 [patent_doc_number] => 12497371 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-16 [patent_title] => DRP-1 inhibitors as therapeutic agents [patent_app_type] => utility [patent_app_number] => 18/971536 [patent_app_country] => US [patent_app_date] => 2024-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 30 [patent_no_of_words] => 6408 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18971536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19875745 [patent_doc_number] => 20250108002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-03 [patent_title] => TOPICAL OCULAR DELIVERY OF CROMAKALIM [patent_app_type] => utility [patent_app_number] => 18/907300 [patent_app_country] => US [patent_app_date] => 2024-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44903 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18907300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20561982 [patent_doc_number] => 12564572 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-03 [patent_title] => Topical ocular delivery of cromakalim [patent_app_type] => utility [patent_app_number] => 18/907296 [patent_app_country] => US [patent_app_date] => 2024-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 40914 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18907296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20115993 [patent_doc_number] => 12365682 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-22 [patent_title] => Process to make GLP1 RA and intermediates therefor [patent_app_type] => utility [patent_app_number] => 18/823214 [patent_app_country] => US [patent_app_date] => 2024-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14429 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18823214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19462321 [patent_doc_number] => 20240315990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-26 [patent_title] => Adelmidrol For Use In Diseases Characterized By Insufficient Agonism Of PPAR-GAMMA Receptor [patent_app_type] => utility [patent_app_number] => 18/736787 [patent_app_country] => US [patent_app_date] => 2024-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5234 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18736787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19430912 [patent_doc_number] => 20240299410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-12 [patent_title] => METHODS OF TREATING FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS BY ORAL ADMINISTRATION OF FASUDIL [patent_app_type] => utility [patent_app_number] => 18/665262 [patent_app_country] => US [patent_app_date] => 2024-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11611 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18665262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19554791 [patent_doc_number] => 20240366583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-07 [patent_title] => THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING MOVEMENT DISORDERS [patent_app_type] => utility [patent_app_number] => 18/655062 [patent_app_country] => US [patent_app_date] => 2024-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 116819 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18655062 [rel_patent_id] =>[rel_patent_doc_number] =>)